Literature DB >> 16527260

Cytochrome P450 expression and metabolic activation of cooked food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in MCF10A breast epithelial cells.

Ronald D Thomas1, Mario R Green, Chantell Wilson, Amy L Weckle, Zhengbo Duanmu, Thomas A Kocarek, Melissa Runge-Morris.   

Abstract

The cytochrome P450 expression profile was determined in the MCF10A human breast epithelial cell line, as was the ability of this cell line to catalyze the bioactivation of the cooked food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Using non-quantitative reverse transcription-polymerase chain reaction (RT-PCR), transcripts for CYP1B1, CYP2J2, CYP2R1, CYP2U1, CYP2W1, CYP4B1, CYP4F, CYP4V2, CYP4X1 and CYP4Z1 were detected in both sub-confluent and confluent MCF10A cells. By contrast, CYP1A2 mRNA was detected only in confluent MCF10A cells, while CYP1A1, CYP2S1 and CYP2F1 were detected predominantly or exclusively in sub-confluent cultures. 2,3,7,8-Tetrachlorodibenzo-p-dioxin treatment of confluent MCF10A cells markedly induced microsomal ethoxyresorufin O-deethylase activity and CYP1A1, CYP1A2 and CYP1B1 mRNA levels, as determined by real-time RT-PCR, while treatment with 10(-4)M PhIP had little effect on these P450 transcript levels. Treatment of confluent MCF10A cells with PhIP (10(-4)M) for 24, 48 or 72 h produced time-dependent increases in the amounts of DNA adducts, as measured by (32)P-post-labeling. These results indicate that multiple P450s, including those known to catalyze PhIP N-oxidation, are expressed in MCF10A cells, and that this non-neoplastic human breast epithelial cell line contains sufficient enzymatic machinery to support PhIP bioactivation and generate DNA damage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16527260     DOI: 10.1016/j.cbi.2006.01.007

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  12 in total

1.  Genetic and epigenetic regulation of AHR gene expression in MCF-7 breast cancer cells: role of the proximal promoter GC-rich region.

Authors:  Neal A Englert; Robert J Turesky; Weiguo Han; Erin E Bessette; Simon D Spivack; Michele Caggana; David C Spink; Barbara C Spink
Journal:  Biochem Pharmacol       Date:  2012-06-21       Impact factor: 5.858

2.  p-Anilinoaniline enhancement of dioxin-induced CYP1A1 transcription and aryl hydrocarbon receptor occupancy of CYP1A1 promoter: role of the cell cycle.

Authors:  Althea Elliott; Aby Joiakim; Patricia A Mathieu; Zofia Duniec-Dmuchowski; Thomas A Kocarek; John J Reiners
Journal:  Drug Metab Dispos       Date:  2012-02-16       Impact factor: 3.922

3.  Regulation of estrogen sulfotransferase expression by confluence of MCF10A breast epithelial cells: role of the aryl hydrocarbon receptor.

Authors:  Jiaqi Fu; Hailin Fang; Michelle Paulsen; Mats Ljungman; Thomas A Kocarek; Melissa Runge-Morris
Journal:  J Pharmacol Exp Ther       Date:  2011-08-09       Impact factor: 4.030

4.  Catalytic Activities of Tumor-Specific Human Cytochrome P450 CYP2W1 Toward Endogenous Substrates.

Authors:  Yan Zhao; Debin Wan; Jun Yang; Bruce D Hammock; Paul R Ortiz de Montellano
Journal:  Drug Metab Dispos       Date:  2016-03-02       Impact factor: 3.922

5.  Diallyl sulfide inhibits PhIP-induced cell death via the inhibition of DNA strand breaks in normal human breast epithelial cells.

Authors:  Ayoola Aboyade-Cole; Selina Darling-Reed; Ebenezer Oriaku; Michael McCaskill; Ronald Thomas
Journal:  Oncol Rep       Date:  2008-08       Impact factor: 3.906

6.  Age- and sex-dependent expression of multiple murine hepatic hydroxysteroid sulfotransferase (SULT2A) genes.

Authors:  Thomas A Kocarek; Zhengbo Duanmu; Hai-Lin Fang; Melissa Runge-Morris
Journal:  Biochem Pharmacol       Date:  2008-08-05       Impact factor: 5.858

7.  Human cyt P450 mediated metabolic toxicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) evaluated using electrochemiluminescent arrays.

Authors:  Sadagopan Krishnan; Eli G Hvastkovs; Besnik Bajrami; John B Schenkman; James F Rusling
Journal:  Mol Biosyst       Date:  2008-12-12

8.  Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression.

Authors:  Jiaqi Fu; Amy M Weise; Josie L Falany; Charles N Falany; Bryan J Thibodeau; Fred R Miller; Thomas A Kocarek; Melissa Runge-Morris
Journal:  Breast Cancer Res Treat       Date:  2009-03-24       Impact factor: 4.872

9.  Synergistic and Antagonistic Mutation Responses of Human MCL-5 Cells to Mixtures of Benzo[a]pyrene and 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]pyridine: Dose-Related Variation in the Joint Effects of Common Dietary Carcinogens.

Authors:  Rhiannon David; Timothy Ebbels; Nigel Gooderham
Journal:  Environ Health Perspect       Date:  2015-06-19       Impact factor: 9.031

10.  Investigation of VOCs associated with different characteristics of breast cancer cells.

Authors:  Luca Lavra; Alexandro Catini; Alessandra Ulivieri; Rosamaria Capuano; Leila Baghernajad Salehi; Salvatore Sciacchitano; Armando Bartolazzi; Sara Nardis; Roberto Paolesse; Eugenio Martinelli; Corrado Di Natale
Journal:  Sci Rep       Date:  2015-08-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.